Navigation Links
Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
Date:10/23/2008

tary rights, operate without infringing upon the proprietary rights of others or prevent others from infringing on the proprietary rights of the Company; and (4) general economic and business conditions and the availability of sufficient financing.

COMMUNICATION INTELLIGENCE CORPORATION

Selected Consolidated Statement of Operations Information

(Dollars in thousands, except per share amounts)

Three Months Ended Nine Months Ended

(unaudited) (unaudited)

09/30/08 09/30/07 09/30/08 09/30/07

Revenues $ 721 $ 456 $ 1,558 $ 1,345

Net loss $ (755) $ (1,105) $ (2,692) $ (2,755)

Net income (loss)

applicable to $ (776) $ (1,105) $ (3,090) $ (2,755)

common stockholders

Basic and diluted income

(loss) per common share $ (0.01) $ (0.01) $ (0.02) $ (0.03)

Weighted average common

shares outstanding 129,057 111,530 129,057 108,891

Selected Consolidated Balance Sheet Information

(Dollars in thousands)

09/30/08 12/31/07

(unaudited)

Cash & cash equivalents $1,276 $1,144

Total current assets $1,998 $1,731

Total assets $7,118 $6,475

Short-term debt (1) $ . $1,370

Deferred revenue (2) $ 266 $ 431

Total current liabilities (3) $1,065 $2,598

Long-term debt related party (4) $2,683
'/>"/>

SOURCE Communication Intelligence Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology news :

1. A private bandwidth for communication in bats: Evidence from insular horseshoe bats
2. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
3. Springer book wins Quality of Communication Award
4. 2 French scientists win European award for communication
5. Scripps research team blocks bacterial communication system to prevent deadly staph infections
6. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results
7. Turning on cell-cell communication wipes out staph biofilms
8. MXI Security and Communication Intelligence Corporation Team up to Deliver the First Green Portable Security Solution for Financial Institutions
9. Communication Intelligence Corporation Closes $3.6 Million Financing
10. Genome communication
11. From humming fish to Puccini: Vocal communication evolved with ancient species
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
(Date:12/2/2009)PHILADELPHIA Exposure to secondhand smoke for a prolonged period of time and in high quantity may increase the risk of breast cancer, even in women who never smoked cigarettes themselves. , "The qu
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7Gen Probe to Webcast Two Upcoming Investor Presentations 5888 1Gen Probe to Webcast Two Upcoming Investor Presentations 5888 2Patients More Likely to Die While in ICU in U S Than in England 60428 1Patients More Likely to Die While in ICU in U S Than in England 60428 2
...ommonwealth University Massey Cancer Center have f...ement of human breast cancer cells toward epiderma...nal of Biological Chemistry, researchers showed th... role in breast cancer progression, stimulates sph...nzymes that forms the potent lipid mediator, sphin...
...ar subtleties of a strain of mice engineered to ag...ion of genetic mutations prompts a cascade of prog... process. , Writing today (July 15, 2005) in the j...sity of Wisconsin-Madison geneticist Tomas A. Prol... normal mice that peel away some of the root secre...
...global health threat. Although more than 3 billion...o fight tuberculosis, the ability of the BCG vacci...ficacy against newly emerging isolates. , In a stu...nt publication of the September 1 issue of the Jou...d colleagues from the Max Planck Institute devise ...
Other Biology News:Elderly mice yield clues to the process of growing old 2Elderly mice yield clues to the process of growing old 3
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...ons is pleased to welcome Richard Duffey, M.D., to...in Mobile, Alabama and also serves patients from P...and Pascagoula communities in Mississippi.,Trusted... LASIK Eye Surgeons directory service and informat...geons.com . What sets the Trusted LASIK Surgeons d...
...tion (OTC: MYMX), will be holding an important con... New York Time to update all shareholders,on the r...Form 10-Q and to,address recent press articles., ...866-591-4361 PIN 815,726 and from Europe at +41-80...Mymetics, primary objective is to develop vaccines...
...aqGS: VARI) introduced its new dual wavelength X-r...les and proteins. The SuperNova(TM) is the,first d...high intensity,micro-source X-ray technology. It i...ata analysis, enabling faster results even for the... diffraction is used to determine the structure of...
Other Biology Technology:Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 2Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 3Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 4Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 5Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers 6New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses 2
T7 RNA Polymerase from Invitrogen
T7 RNA polymerase from Chimerx
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
RNase H from Roche Applied Science
Biology Products: